Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
Clinical trial NCT01795313 · TERMINATED
Trial details
- NCT number
- NCT01795313
- Sponsor
- James Felker
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2025-12-03
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.